Anafranil
Anafranil

1.01
Developed to mitigate obsessive compulsive behaviors to support mental health and target neurotransmitter reuptake.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Clomipramine
Reference Brand
Clomipramine
Product Origin
Generic Alternative
Reference Manufacturer
Mallinckrodt
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidepressants
Product Category
Tricyclic Antidepressant (TCA)
Pharmacological Class
Tricyclic Antidepressant
Manufacturer Description
Developed to mitigate obsessive compulsive behaviors to support mental health and target neurotransmitter reuptake.
Mechanism of Action
Inhibits the membrane reuptake of norepinephrine and serotonin, restoring balance to central neural communication pathways.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Recent myocardial infarction, Concurrent use of MAO inhibitors, Severe cardiovascular disease
Severe Adverse Events
Suicidal ideation — requires immediate medical attention, Serotonin syndrome — requires immediate medical attention
Common Side Effects
Dry mouth, Dizziness, Somnolence
Uncommon Side Effects
Constipation, Weight gain, Sexual dysfunction
Drug Interactions
MAO Inhibitors, Alcohol, Fluoxetine
Pregnancy Safety Warnings
TGA Category C: Potential neonatal withdrawal symptoms. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for children over five years, adolescents, and adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Anafranil is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Bone Health AU - Rocaltrol Australia